WHO WE ARE
ABOUT US
AGE OF EVIDENCE
LEADERSHIP
Executive Team
Board of Directors
Advisors
CONTACT US
WHAT WE DO
OUR APPROACH
OUR TECHNOLOGY
OUR PRODUCTS
OVERVIEW
AFIRMA&REG;
PERCEPTA&REG;
ENVISIA&TRADE;
PIPELINE
PUBLICATIONS & ABSTRACTS
SAFETY DATA SHEETS & LICENSES
INVESTORS
OVERVIEW
PRESS RELEASES
EVENTS & PRESENTATIONS
CORPORATE GOVERNANCE
Executive Leadership
Board of Directors
Committee Composition
SEC FILINGS
STOCK INFORMATION
ANALYST COVERAGE
INVESTOR FAQS
INFORMATION REQUESTS
NEWSROOM
PRESS RELEASES
IN THE NEWS
CORPORATE RECOGNITION
MEDIA RESOURCES
SIGN UP FOR NEWS UPDATES
JOIN OUR TEAM
OUR CULTURE
JOB OPENINGS
SEARCH
WHO WE ARE
ABOUT US
AGE OF EVIDENCE
LEADERSHIP
Executive Team
Board of Directors
Advisors
CONTACT US
WHAT WE DO
OUR APPROACH
OUR TECHNOLOGY
OUR PRODUCTS
OVERVIEW
AFIRMA&REG;
PERCEPTA&REG;
ENVISIA&TRADE;
PIPELINE
PUBLICATIONS & ABSTRACTS
SAFETY DATA SHEETS & LICENSES
INVESTORS
OVERVIEW
PRESS RELEASES
EVENTS & PRESENTATIONS
CORPORATE GOVERNANCE
Executive Leadership
Board of Directors
Committee Composition
SEC FILINGS
STOCK INFORMATION
ANALYST COVERAGE
INVESTOR FAQS
INFORMATION REQUESTS
NEWSROOM
PRESS RELEASES
IN THE NEWS
CORPORATE RECOGNITION
MEDIA RESOURCES
SIGN UP FOR NEWS UPDATES
JOIN OUR TEAM
OUR CULTURE
JOB OPENINGS
Knowing
This is the Age of Evidence. 
Where a new definition of diagnostic truth is changing patient care as we know it. Where physicians and patients can now benefit from the evolution of healthcare and know, by design, the answers they seek.
Veracyte gives patients a clearer path for the future.
We are leading in the Age of Evidence.
our impact
The Age 
of Evidence
Veracyte's genomic tests have the potential to save billions of dollars each year in unnecessary surgery costs.
Learn More >
Answers That Set New Standards
Veracyte’s CEO named as one of 2017’s Fiercest Women in Life Sciences
learn more >
latest news
Bonnie Anderson, Veracyte CEO, speaks with Bill Vick of PF Warriors about Envisia Genomic Classifier
learn more >
Veracyte CEO Says RNA Sequencing Data Will Drive Future Pharma Deals, Products
learn more >
Novel Genomic Sequence Classifier Improves Detection of Benign Thyroid Nodules
learn more >
Tweets by Veracyte
Who We Are
Who We Are
About Us
Age of Evidence
Leadership
Executive Team
Board of Directors
Advisors
Contact Us
What We Do
What We Do
Our Approach
Our Technology
Our Products
Our Products
Overview
Afirma®
Percepta®
Envisia™
Pipeline
Publications & Abstracts
Safety Data Sheets & Licenses
Investors
Investors
Overview
Press Releases
Events & Presentations
Corporate Governance
Executive Leadership
Board of Directors
Committee Composition
SEC Filings
Stock Information
Analyst Coverage
Investor FAQs
Information Requests
Newsroom
Newsroom
Press Releases
In The News
Corporate Recognition
Media Resources
Sign Up For News Updates
Join Our Team
Join Our Team
Our Culture
Job Openings
Veracyte Headquarters
Driving Directions
Veracyte – Austin
Driving Directions
Contact Us
Privacy Policy
 | 
Terms and Conditions